Could cause temporary or reversible harm; serious harm is unlikely.
Failed Impurities/Degradation Specifications
| Brand name | FOSFOMYCIN TROMETHAMINE |
| Generic name | FOSFOMYCIN TROMETHAMINE |
| Active ingredient(s) | FOSFOMYCIN TROMETHAMINE |
| Distributed by / for | Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059 |
| NDC | 69097-579-67 |
| Full product label | Fosfomycin Tromethamine Granules for Oral Solution, (Equivalent to 3 Grams of Fosfomycin), 1 Single-Dose Sachet, Rx only, Manufactured by: Cipla Ltd., Kurkumbh-413802, Maharashtra, India, Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059, NDC 69097-579-67. |
| Recalling firm | Cipla USA, Inc. |
| Distribution | USA Nationwide. |
| Quantity | N/A |
| Recall initiated | 2026-09-18 |
| Report date | 2026-10-14 |
| Recall completed | — |
| Recall number | D-0014-2027 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Warren NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗